Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
EpiCast Report: Migraine - Epidemiology Forecast to 2023

Epidemiologists forecast the total prevalent migraine cases to remain relatively constant to total 76.4Mn cases by 2023


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-04-30 05:19:01 - EpiCast Report: Migraine - Epidemiology Forecast to 2023 - a new market research report on companiesandmarkets.com

Migraine is typically characterized by recurring headaches, throbbing pain on one side of the head along with one or more of the following symptoms: nausea; vomiting; and increased sensitivity to light, sound and smell (Bigal and Lipton, 2006). This disabling neurological disorder can have serious consequences, such as permanent brain damage (Chronicle and Mulleners, 1994; Diener et al., 2006). The lifetime prevalence of migraine in men ranges from 6% in France to 12% in Denmark, and in women ranges from 15% in Germany to 25% in Denmark (Gobel et al., 1994). Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized

 

 

as a high-priority public health problem by the World Health Organization (WHO) (Leonardi et al., 2005; Lusić, 2001). The Global Burden of Disease (GBD) study in 2010 ranks migraine as the first among the neurological disorders (Leonardi and Raggi, 2013).

Epidemiologists forecast that the total prevalent cases of migraine in the 7 major markets remained almost the same, with 75,832,518 total prevalent cases in 2013 and 76,377,456 total prevalent cases in 2023, with an annual growth rate (AGR) of 0.07% in the forecast period. Throughout the forecast period, the US will have the highest number of total prevalent cases of migraine, with 29,610,796 total prevalent cases in 2013 and 31,137,451 total prevalent cases in 2023. Given that migraine typically occurs in young adults, affecting the quality of life and social development of the individuals, early diagnosis and better management of the condition are imperative to combat the global burden and to prevent the progression of the condition to severe stages.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com